Ramirez Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.6M Buy
15,509
+14,081
+986% +$14.4M 1.94% 6
2026
Q1
$1.31M Sell
1,428
-82
-5% -$83.1K 0.16% 123
2025
Q4
$1.62M Hold
1,510
– – 0.21% 121
2025
Q3
$1.15M Buy
1,510
+568
+60% +$423K 0.16% 134
2025
Q2
$734K Hold
942
– – 0.11% 148
2025
Q1
$778K Buy
+942
New +$784K 0.16% 140

Other funds holding LLY

Ramirez Asset Management's LLY Position: Q2 2026 in Review

Ramirez Asset Management increased its Eli Lilly (LLY) stake by 986% in Q2 2026, buying an estimated $14.4M and bringing the position to 15,509 shares worth $18.6M. The position accounts for 1.94% of the portfolio, ranked #6.

Ramirez Asset Management first reported a position in LLY in Q1 2025 and has held it in 6 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Ramirez Asset Management held 15,509 shares of Eli Lilly worth $18.6M as of Q2 2026.
  • Ramirez Asset Management bought 14,081 Eli Lilly shares in Q2 2026, an estimated $14.4M.
  • Eli Lilly made up 1.94% of Ramirez Asset Management's portfolio in Q2 2026, its #6 holding.
  • Ramirez Asset Management first reported a position in Eli Lilly in Q1 2025 and has held it in 6 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Ramirez Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.